Fluid injection apparatus with improved contrast visualization
Abstract
An apparatus and method for manually injecting fluid into a patient with improved contrast visualization are disclosed. The apparatus includes a syringe having a cylinder in which a plunger is reciprocatingly mounted. The syringe is connected to a manifold which itself is connected to a source of radiopaque contrast. Retraction of the plunger within the cylinder draws contrast into the cylinder, and depression of the plunger forces the contrast through the manifold and into a patient through a catheter. In order to increase the speed of injection and thus the visualization of the contrast, an improved visualization device is provided which may be provided in the form of a heater or, alternatively, in the form of an expandible catheter. The heater may be positioned anywhere within the apparatus to elevate the temperature of the contrast material, which in turn reduces its viscosity and thereby increases the speed with which fluid may be injected. The expandible catheter, may be used to restrict blood flow through a vascular structure so that the contrast material may be injected into the patient with lessened resistance and dilution from blood flow.

Term
Term ended
Expired 27 July 2021, 5.2 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
7 claims: 7 independent, 0 dependent
- 1An angiographic device (20), comprising:a catheter (32) to be inserted into a blood vessel;a source of radiopaque fluid (22);an injector (24) fluidically connected to the source of radiopaque fluid (22) and the catheter (32), the injector being adapted to drive the radiopaque fluid from the source to the catheter (32) and into the blood vessel;characterised in thatan expandable ring (74) is provided on the catheter (32), the expandable ring (74) being adapted to constrict blood flow through the blood vessel when expanded thus decreasing the speed with which the radiopaque fluid is diluted in the blood vessel. Angiographische Vorrichtung (20), umfassend einen in ein Blutgefäß einzuführenden Katheter (32);eine Quelle von Kontrastflüssigkeit (radiopaque fluid) (22);einen mit der Quelle der Kontrastflüssigeit (22) und dem Katheter (32) fluidisch verbundenen Injektor (24), wobei der Injektor dazu ausgebildet ist, die Kontrastflüssigkeit von der Quelle zu dem Katheter und in das Blutgefäß zu treiben;dadurch gekennzeichnet, dass ein dehnbarer Ring (74) an dem Katheter (32) vorgesehen ist, wobei der dehnbare Ring (74) dazu ausgebildet ist, einen Blutstrom durch das Blutgefäß einzuengen, wenn der Ring gedehnt wird, so dass die Geschwindigkeit, mit der die Kontrastflüssigkeit in dem Blutgefäss verdünnt wird, verringert wird. Un dispositif angiographique (20), comprenant : un cathéter (32) destiné à être inséré dans un vaisseau sanguin;une source de fluide radio-opaque (22);un injecteur (24) en communication pour le passage de fluide avec la source de fluide radio-opaque (22) et le cathéter (32), l'injecteur étant adapté pour entraîner le fluide radio-opaque à partir de la source vers le cathéter (32) et jusque dans le vaisseau sanguin;caractérisé en ce queun anneau dilatable (74) est monté sur le cathéter (32), l'anneau dilatable (74) étant adapté pour étrangler l'écoulement de sang à travers le vaisseau sanguin lorsqu'il est dilaté, en diminuant ainsi la vitesse à laquelle le fluide radio-opaque est dilué dans le vaisseau sanguin.
- 2Angiographische Vorrichtung nach Anspruch 1, wobei der Injektor eine Injektionsspritze (24) ist. Le dispositif angiographique de la revendication 1, dans lequel l'injecteur est une seringue (24). The angiographic device of claim 1, wherein the injector is a syringe (24).
- 3Angiographische Vorrichtung nach Anspruch 2, wobei die Injektionsspritze (24) manuell betätigt wird. Le dispositif angiographique de la revendication 2, dans lequel la seringue (24) est actionnée manuellement. The angiographic device of claim 2, wherein the syringe (24) is manually operated.
- 4Angiographische Vorrichtung nach Anspruch 1, ferner umfassend ein Verteilerrohr (26) mit einer Mehrzahl von Anschlüssen (58a, b und c), wobei der Injektor, die Quelle (22) sowie der Katheter (32) jeweils mit einem der Anschlüsse (58a, b und c) verbunden ist. Le dispositif angiographique de la revendication 1, incluant en outre un collecteur (26) ayant une multiplicité d'orifices (58a, b et c), l'injecteur, la source (22) et le cathéter (32) étant branchés chacun à l'un des orifices (58a, b et c). The angiographic device of claim 1, further including a manifold (26) having a plurality of ports (58 a, b and c), the injector, source (22), and the catheter (32) each being connected to one of the ports (58a, b and c).
- 5Angiographische Vorrichtung nach Anspruch 1, ferner umfassend eine Heizvorrichtung (76), welche die Kontrastflüssigkeit erwärmt, wobei die Heizvorrichtung (76) die Viskosität der Kontrastflüssigkeit verringert, so dass die Geschwindigkeit, mit der die Kontrastflüssigkeit in das Blutgefäß eingeführt wird, vergrößert wird. Le dispositif angiographique de la revendication 1, incluant en outre un élément chauffant (76) qui chauffe le fluide radio-opaque, l'élément chauffant (76) réduisant la viscosité du fluide radio-opaque et augmentant ainsi la vitesse à laquelle le fluide radio-opaque est introduit dans le vaisseau sanguin. The angiographic device of claim 1, further including a heater (76) heating the radiopaque fluid, the heater (76) reducing the viscosity of the radiopaque fluid thus increasing the speed with which the radiopaque fluid is introduced into the blood vessel.
- 6Angiographische Vorrichtung nach Anspruch 5, wobei die Heizvorrichtung (76) in einem der Teile Injektor, Katheter (32) oder Quelle (22) integriert ist. Le dispositif angiographique de la revendication 5, dans lequel l'élément chauffant (76) est intégré dans l'un de l'injecteur, du cathéter (32) et de la source (22). The angiographiy device of claim 5, wherein the heater (76) is integrated into one of the injector, catheter (32), and source (22).
- 7Angiographische Vorrichtung nach Anspruch 5, wobei die Heizvorrichtung (76) eine Form des Erhitzens verwendet, welche aus der Gruppe von Erhitzungsformen ausgewählt ist, die aus Strahlungserwärmung, Konvektionserwärmung und Erwärmung durch Wärmeleitung besteht. Le dispositif angiographique de la revendication 5, dans lequel l'élément chauffant (76) emploie une forme de chauffage sélectionnée dans le groupe de formes de chauffage comprenant le chauffage par rayonnement, convection et conduction. The angiographiy device of claim 5, wherein the heater (76) employs a form of heating selected from the group of heating forms consisting of radiant, convective, and conductive heating.
Independent claims7
27 paragraphs in 5 sections, as filed
FIELD OF THE INVENTION
The invention generally relates to fluid injection apparatus and, more particularly, relates to manually operated syringes.
BACKGROUND OF THE INVENTION
Many medical procedures require the injection of fluid. One example is angiography. Angiography is a procedure used in the detection and treatment of abnormalities or restrictions in blood vessels. During angiography, a radiographic image of a vascular structure is obtained by injecting radiopaque fluid or contrast through a catheter into a vein or artery. Vascular structure fluidically connected with the vein or artery in which the injection occurs is filled with the contrast material. X-rays are then passed through the region of the body in which the contrast material was injected, with the x-rays being absorbed by the contrast material, creating a radiographic outline or image of the blood vessel containing the contrast material. The x-ray image of the blood vessels filled with the contrast material is usually recorded onto film or videotape and then displayed on a fluoroscope monitor.
The speed with which the injection of contrast occurs enhances the resulting radiographic image because the speed of injection counteracts the flow of blood through the vessels that continually carries or flushes the contrast away. The faster the injection of contrast means a higher concentration of the contrast during the x-ray imaging and therefore a higher radiopacity of the blood vessels. Due to the high viscosity of the contrast material, and the flow resistance in the catheter and other fluid channels, the force required for rapid injection of a contrast is relatively high.
An additional factor contributing to the high forces required for plunger depression is that as current technology has evolved, the catheters used for angiography have reduced in size. The outlet diameters of the catheters have been reduced to four or five French size catheters. As a result, the force required to inject into the arteries has increased significantly.
Currently, manual syringes are used to inject contrast into most arteries. When large flow rates of contrast are required, as is the case forventrilography (injecting into the left ventricle), a power injector is typically used because manual syringes cannot be operated with sufficiently high flow rate due to the inability to apply enough manual force on the syringe plunger.
The power injector is operated by first setting a flow rate and an injection volume. The operator then activates the system by pressing a button on a hand controller which actuates a motor or the like for injecting the contrast. Examples of such power injectors are disclosed in U.S. Patent Nos. 5,515,851 and 5,916,165. Other pumping / injection systems for injecting a liquid medium into a patient by using electronic control systems are for example disclosed in U.S. Patents Nos. 5,827,219, 5,885,216 and 6,099,502. Finally, European publication EP 702 966 A1 discloses a contrast media delivery system comprising the features defined in the preamble of claim 1 which allows an adjustment of contrast media concentration and injection parameters either before or during an injection procedure to provide patient specific dosing of contrast media.
However, while such power injectors and electronically controlled injection systems are preferable in certain applications, in other instances, it would be advantageous to use a manual syringe. One advantage of using a manual syringe is that the operator is provided with more direct control of the injection. For example, if resistance is encountered during the injection process, the operator can detect the resistance due to an increase in the pressure, and thus the force required to manually depress the plunger.
It would therefore be advantageous to provide a fluid injection apparatus which enables the injection to be performed manually, but which reduces the force required for such manual operation without employing a power injector.
SUMMARY OF THE INVENTION
In accordance with the present invention, an angiographic device is provided which comprises the features defined in claim 1.
In accordance with a preferred embodiment of the present invention, the injector is a syringe which is preferably manually operated.
The angiographic device of the present invention can further include a manifold having a plurality of ports, wherein the injector, the source of radiopaque fluid and the catheter each are connected to one of the ports of said manifold. In particular, the injector is connected to the first end of the manifold whereas the catheter is connected to the second end of the manifold. The source of fluid is in communication with one of the further manifold inlet ports via a fluid line, while the expandable ring is associated with the catheter and is expandable after catheter insertion and prior to injection to constrict blood flow.
In order to further improve the angiographic device of the present invention, a heater can be provided for heating the radiopaque fluid. The heater reduces the viscosity of the radiopaque fluid and thus increases the speed with which the radiopaque fluid is introduced into the blood vessel. The heater can be integrated into one of the injector, catheter and source and preferably employs a form of heating selected from the group of heating forms consisting of radiant, convective, and conductive heating.
These and other aspects and features of the invention will become more apparent from the following detailed description when taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
<ul id="ul0001" list-style="none" compact="compact"><li>FIG. 1 is a schematic representation of a manual fluid injection apparatus constructed in accordance with the teachings of the invention;</li><li>FIG. 2 is a block diagram of an alternative embodiment of a fluid injection apparatus constructed in accordance with the teachings of the invention; and</li><li>FIG. 3 is a flow chart of a sample sequence of steps which may be taken by a fluid injection system constructed in accordance with the teachings of the invention.</li></ul>
While the invention is susceptible to various modifications and alternative constructions, certain illustrative embodiments thereof have been shown in the drawings and will be described below in detail. It should be understood, however, that there is no intention to limit the invention to the specific forms disclosed, but on the contrary, the intention is to cover all modifications, alternative constructions falling within the scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring now to the drawings, and with specific reference to FIG. 1, a manually operated fluid injection apparatus constructed in accordance with the teachings of the invention is generally depicted by reference numeral 20. The apparatus 20 is depicted in reference to a manually operated apparatus 20 for the injection of radiopaque contrast from a supply 22 to a patient (not shown). However, it is to be understood that the teachings of the invention can be used for the injection of other fluids as well, and in power-assisted, or automatic injection systems as well.
As shown in FIG. 1, the apparatus 20 includes a manually operated syringe 24, a manifold 26, a first fluid line 28, a second fluid line 30, a catheter 32, and an improved visualization device 34.
The syringe 24 includes a cylinder 36 in which a plunger 38 is disposed for translational movement. The plunger 38 includes a thumb ring 40, as well as a rubber or otherwise elastomeric stopper 42 engaging an inner circumferential surface 44 of the cylinder 36. First and second finger rings 46 and 48 extend from the cylinder 36 to facilitate operation of the syringe 24 in conjunction with the thumb ring 40. The cylinder 36 includes a reduced diameter outlet 50 connected to a first end 52 of the manifold 26. A threaded or other suitable coupling 54 is provided for attachment therebetween.
The manifold 26 includes the first end 52, a second end 56, and a plurality of valved inlet ports 58a, b, and c. As shown in FIG. 1, inlet port 58c is connected to the first fluid line 28 for receipt of contrast from the supply 22. The second inlet port 58b, is connected to a source of saline 60 by way of the second fluid line 30. The third inlet port 58a, is shown connected to a pressure transducer 64. The second end 56 of the manifold 26 is connected to the catheter 32.
The first fluid line 28, connecting the source of contrast 22 to the manifold 26, may include a valve 66 as well as a vent 68. The valve 66, which may be provided in the form of a stop cock, is provided to control flow of contrast from the source of contrast 22 to the manifold 26. The vent 68, is provided to aerate any air or gas within the first fluid line 28.
The catheter 32 includes a proximal end 70, and a distal end 72. As shown in FIG. 2, the distal end 72 of the catheter 32 is according to the invention provided with an expandable ring 74, the importance of which will be discussed in further detail herein. The expandable ring 74 may be provided in the form of an elastomeric hollow ring which upon introduction of compressed air or the like, may expand to increase the diameter of the catheter 32.
Referring again to FIG. 1, the improved visualization device 34 is shown proximate the catheter 32. The improved visualization device 34 may additionally comprise a heater. The heater 76 can be provided in a variety of radiant, convective and conductive forms, including conventional heating coils which, upon electrical actuation, elevate temperature to thereby increase the temperature of the catheter 32 and thus the temperature of the contrast within the catheter 32. Alternatively, the heater 76 may be provided in the form of conduits or tubes wrapped around the catheter 32 or other parts of the apparatus 20 and through which a relatively warm fluid is passed for heating of the contrast. In a still further alternative, the heater 76 may be embedded directly in the apparatus 20. More specifically, resistor coils or other heating devices may be provided in the body of the syringe 24, the manifold 26, the first fluid line 28, the second fluid line 30, or the catheter 32. However, the inventor has found that it is beneficial to provide the heater 76 as close to the end of the catheter 32 inserted into the patient as possible to lessen the cooling effects of traveling through the apparatus 20.
The improved visualization devices 34 are provided to increase the speed with which the contrast may be injected to thereby minimize the effect of blood flow washing the contrast away and lessening the visual radiographic image generated. In the embodiment employing the heater 76, the speed is increased by elevating the temperature of the contrast, which in turn decreases its density and decreases its viscosity. Accordingly, the contrast is more easily injected. By means of the expandable ring 74, the size of the catheter 32 is increased after placement within the vascular structure of the patient. In so doing, blood flow is restricted through the vascular structure, momentarily, while the contrast is injected. The contrast therefore is injected with less mixing with blood flow and less dilution of the contrast. After injection of the contrast, the expandable ring can be deflated and the catheter 32 can be removed thereby allowing blood flow to return to normal. The heater 76 and the expandable ring 74 may be combined in the same system or apparatus 20.
In operation, the apparatus 20 may be used to inject fluid into a patient with increased speed. As shown in FIG. 3, which is a sample depiction of steps which may be taken by the apparatus 20, after the valve 66 is opened, the process is initiated by opening the valved port 58c, as indicated by step 78. In so doing, fluid flow is communicated from the source of contrast 22, through the manifold 26 and to the outlet 50 of the syringe 24. The contrast 22 is able to enter the cylinder 36 of the syringe 24 upon retraction of the plunger 38, as indicated by step 80. More specifically, the retraction of the plunger 38 within the cylinder 36 creates a vacuum within the cylinder 36, thereby drawing the contrast into the syringe 24. The plunger 38 may be retracted a distance sufficient to fill the cylinder 36 to the appropriate volume. A series of indicia or graduations may be provided on the side of the cylinder to facilitate such operation.
Once the syringe 24 is filled to the appropriate volume, the plunger 38 is reciprocated back into the cylinder 36 as indicated by step 82. In so doing, the contrast 22 is forced from the cylinder 36 into the manifold 26, through the catheter 32, and into the patient. While passing through the components of the apparatus 20, the contrast fluid 22 is heated, as indicated by step 84. In so doing, the density and viscosity of the contrast 22 are decreased, and the force required by the user to depress the plunger 38 is decreased, and the speed of injection is increased.
In step 86, the catheter 32 is expanded in conjunction with the heating step 84. In so doing, the catheter 32 restricts blood flow through the vascular structure in which the catheter 32 is placed. The contrast 22 can therefore be injected into the patient in step 88 with lessened interference and dilution from blood flow. Once the contrast 22 is fully injected, the catheter can be deflated and removed. It is to understood that the expansion of the catheter step 86 may be conducted in the absence of the heating step 84.
From the foregoing, it can be seen by one of ordinary skill in the art that the teachings of the invention may be utilized to provide a manual fluid injection apparatus which reduces the force required by an operator to manually inject fluid into a patient, increases the speed of injection, and improves the contrast visualization on the resulting radiographic image.
Contents5
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| EP0702966A | Cites | European Patent Office (EPO) |
| US5827219A | Cites | United States of America |
| US5885216A | Cites | United States of America |
| US6099502A | Cites | United States of America |
11 members in 7 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 797473 | United States of America | – | |
| 79747301 | United States of America | A | |
| 79747301 | United States of America | A | |
| 0123645 | United States of America | W | |
| 0123645 | United States of America | W | |
| 797473 | – | – | – |
| US2001023645 | – | – | – |
| US20010797473 | – | – | – |
| WO2001US23645 | – | – | – |
Members11
| Document | Office | Kind | |
|---|---|---|---|
| US2002123737A1 | United States of America | A1 | |
| CA2438399A1 | Canada | A1 | |
| WO02070043A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP1363686A1 | European Patent Office (EPO) | A1 | |
| US6699232B2 | United States of America | B2 | |
| US2004167401A1 | United States of America | A1 | |
| JP2004526494A | Japan | A | |
| EP1363686B1This record | European Patent Office (EPO) | B1 | |
| AT332718T | Austria | T | |
| ATE332718T1 | Austria | T1 | |
| DE60121474D1 | Germany | D1 |
42 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation not filedEN | EN | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1363686
- Publication, DOCDB
- 1363686
- Publication, EPODOC
- EP1363686
- Application
- 1957283
- Application, DOCDB
- 01957283
- Application, EPODOC
- EP20010957283
Titles3
- German
- FLUIDINJEKTIONSVORRICHTUNG MIT VERBESSERTER KONTRASTVISUALISIERUNG
- English
- FLUID INJECTION APPARATUS WITH IMPROVED CONTRAST VISUALIZATION
- French
- DISPOSITIF D'INJECTION DE FLUIDE A VISUALISATION PAR CONTRASTE AMELIOREE
Classification
- CPC, 3
- A61M5/44
- A61M5/007
- A61M5/1408
- IPC, 4
- A61M5 00
- A61M5 44
- A61M5 148
- A61M5 14
Designated states20
- Contracting states, 20
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye